Alibaba Agrees To $600 Million DOJ Settlement

Alibaba and its payment affiliate, AUS Merchant Services, have agreed to pay $600 million to resolve a U.S. Department of Justice investigation into allegations that their platforms facilitated the illegal import of pharmaceuticals and pill-making equipment into the United States.

The settlement covers alleged compliance failures spanning from January 2016 through December 2024.

Federal agencies, including the Food and Drug Administration and IRS Criminal Investigation, conducted more than 40 undercover purchases during the investigation to examine the platform's safeguards.

AUS Merchant Services also acknowledged deficiencies in its anti-money laundering program that allowed payment processing for prohibited transactions.

The settlement ranks among the largest Justice Department resolutions involving a Chinese technology company over compliance failures and underscores the U.S. government's continued focus on preventing the online sale and distribution of illegal pharmaceuticals and related equipment.

Related Tweet:

Alibaba to pay $600 million to resolve US drug sales probe https://t.co/SkdSitJHUv https://t.co/SkdSitJHUv

— Reuters (@Reuters) July 1, 2026

Also Read:

New Mexico Opens Criminal Probe Into DEA Fentanyl Operations

The strategy has drawn scrutiny amid the ongoing fentanyl crisis and the agency’s public warnings about the drug’s deadly impact on communities across the United States.

tippinsightsTIPP Staff